FDA approves first generic of Advair Diskus® inhaler for asthma and COPD

This content is crossposted from our Optum Insights blog. The U.S. Food and Drug Administration (FDA) has approved the first generic version of Advair Diskus® (fluticasone propionate and salmeterol inhalation powder). Mylan is the first company to obtain FDA approval to market its generic inhaler. Advair Diskus, manufactured by GlaxoSmithKline, received its FDA approval in … Read moreFDA approves first generic of Advair Diskus® inhaler for asthma and COPD

Medicare’s Coordination of Benefits Energizes Prescription Part D Plans to Recover Conditional Payments

Issue We have observed an increase in notices being provided to workers’ compensation, no-fault auto and premises coverages, liability insurers, and claimants in recent months requesting information so that coordination of benefits (COB) can occur for claimants who are current Medicare beneficiaries. In an effort to get to the bottom of the frequency of these … Read moreMedicare’s Coordination of Benefits Energizes Prescription Part D Plans to Recover Conditional Payments